Stefan Duensing

4PUBLICATIONS
26CO-AUTHORS
Requirements engineeringMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Oct 21, 2020
PARP inhibition in prostate cancer.

Cathleen Nientiedt, Anette Duensing, Stefanie Zschäbitz

|Sep 25, 2019
The BRCA2 mutation status shapes the immune phenotype of prostate cancer.

Maximilian Jenzer, Peter Keß, Cathleen Nientiedt

|Jan 12, 2019
Cullin 5 is a novel candidate tumor suppressor in renal cell carcinoma involved in the maintenance of genome stability.

María Ángeles Tapia-Laliena, Nina Korzeniewski, Samuel Peña-Llopis

Pageof 1